Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Curetis Launches Unyvero LRT Panel for BAL Specimens in U.S. (2020-01-14)
> Panel also includes atypical pathogens such as Pneumocystis jirovecii > LRT BAL Panel expected to substantially increase total addressable market for Unyvero System in the U.S. Curetis N.V. (the "Company" and, together with its subsidiaries, "Curetis"), a...
Vivoryon & Nordic Bioscience Enter into R&D Collaboration (2020-01-14)
Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) and Nordic Bioscience, announced today an agreement to collaborate for the clinical development of PQ912 for Alzheimer’s Disease (AD). In addition to taking on the role as CRO (Clinical Research ...
NBE Therapeutics Closes $22m Series C Led by BIVF & PPF (2020-01-10)
Boehringer Ingelheim Venture Fund and PPF lead the closing of a USD 22M Series C financing round for NBE-Therapeutics NBE-Therapeutics AG today announces the closing of a USD 22M Series C financing round, led by its existing shareholders Boehringer Ingelheim V...
Karl Naegler Joins Wellington Partners as Managing Partner (2020-01-08)
Wellington Partners, a leading European venture capital firm investing in early- and growth-stage life science companies, today announced that Dr. Karl Naegler joined Wellington as a Managing Partner on January 1, 2020. Karl brings to Wellington a strong track reco...
NorthSea Therapeutics €36m Series B Round Led by venBio (2020-01-08)
> Two new US investors; lead investor, venBio Partners and Sofinnova Investments, join syndicate of existing investors > Richard Gaster, M.D., Ph.D., Principal at venBio Partners, and Maha Katabi, Ph.D., CFA, Partner at Sofinnova Investments join the Board > ...
Galecto Biotech AB & PharmaAkea Inc. Announce Merger (2020-01-07)
> Clinical programs in IPF, NASH and cancer > Joint entity to be named Galecto, Inc. Galecto, the leading developer of galectin modulators for the treatment of fibrotic diseases including idiopathic pulmonary fibrosis (IPF) and cancer, and PharmAkea, Inc., ...
Bone Therapeutics Appoints Miguel Forte as CEO (2019-12-19)
BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to address highly unmet medical needs in orthopaedics and bone diseases, today announces the appointment of Dr...
Cellestia Biotech Closes CHF20m Series B Financing Round (2019-12-17)
Cellestia Biotech AG successfully closes Series B financing round, raising a total of CHF 20 million. Guido Guidi elected new Chairman of the Board of Directors and Robert Karsunky elected new Chairman of the Audit Committee and Board of Directors Member. > F...
Augustine Therapeutics Raises €4.2m Seed Round (2019-12-16)
Today, VIB and KU Leuven present a new venture, Augustine Therapeutics, with the mission to develop innovative therapeutics for patients suffering from Charcot-Marie-Tooth disease. Augustine raises a seed-round of 4.2 million euro with V-Bio Ventures, PMV, Advent ...
Promethera Adds €7.5m & Closes Series D with Total of €47.2m (2019-12-16)
Promethera® Biosciences SA, a global innovator in cell-based medicines and liver diseases, today announced the addition of €7.5 million to its recent €39.7 million Series D financing led by new investors Sony Innovation Fund by IGV and Pegasus Tech Ventures. MEDIPA...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

» top